| Contents | 7 |
---|
| Contributors | 9 |
---|
| 1 Cardiovascular CT Angiography: Concepts Important to Image Acquisition and Reconstruction | 13 |
---|
| 1.1 Concepts for Image Acquisition | 13 |
| 1.2 Preview Scans | 15 |
| 1.3 Image Reconstruction and Analysis | 17 |
| 1.4 Clinical Data with Coronary Artery Calcification | 13 |
| 1.4.1 Risk Stratification in Asymptomatic Patients | 21 |
| 1.5 Coronary Calcium -- Basis and Background | 17 |
| 1.6 Coronary Artery Calcification and Obstructive Disease | 17 |
| 1.6.1 Prediction of Events in Asymptomatic Persons using Coronary Calcium | 22 |
| 1.7 Clinical Pearls for Coronary Calcium Assessment | 17 |
| 2 Cardiovascular CT Imaging: Essentials for Clinical Practice | 27 |
---|
| 2.1 Patient Selection and Indications for Coronary CTA | 27 |
| 2.2 Patient Preparation | 28 |
| 2.3 IV Placement | 29 |
| 2.4 Hydration Policy | 29 |
| 2.5 Pre-Procedure Patient Medication | 29 |
| 2.6 Contrast Issues | 30 |
| 2.7 Conclusion | 32 |
| 3 Cardiovascular Calcium: Assessment and Impact of Interventions | 34 |
---|
| 3.1 Imaging Pearls | 37 |
| 4 Assessment of Cardiac Function | 40 |
---|
| 4.1 Introduction | 40 |
| 4.2 Nomenclature | 40 |
| 4.3 Methods | 41 |
| 4.4 Ventricular Anatomy and Function | 42 |
| 4.5 Chamber Measurements | 44 |
| 4.6 Indications/Appropriateness | 45 |
| 4.7 Conclusions | 45 |
| 4.8 Imaging Pearls | 47 |
| 5 CTA as an IVUS Equivalent: Plaque Characterization and Percutaneous Coronary Intervention | 50 |
---|
| 5.1 Quantitative CTA | 50 |
| 5.2 Plaque Characterization | 51 |
| 5.3 CTA-Guided PCI | 55 |
| 5.3.1 Clinical Paradigm | 55 |
| 5.4 Optimal Stent Deployment | 57 |
| 5.5 Conclusions | 58 |
| 5.6 Imaging Pearls | 58 |
| 6 Coronary Angiography of Native Vessels | 60 |
---|
| 6.1 Spatial Resolution | 61 |
| 6.2 Coronary CTA for Identification of Native Vessel Coronary Stenoses | 61 |
| 6.3 Limitations Specific to Coronary CTA | 62 |
| 6.4 Imaging Pearls | 63 |
| 7 Coronary CT Angiography after Percutaneous Coronary Intervention | 68 |
---|
| 7.1 Introduction | 68 |
| 7.2 Current State of the Literature | 69 |
| 7.3 Strengths and Limitations | Indications and Contraindications |
| 7.4 Comparison to Other Modalities | 71 |
| 7.5 Future Directions | 71 |
| 7.6 Imaging Pearls | 72 |
| 7.6.1 Patient Preparation | 72 |
| 7.6.2 Opacification and Scanning | 72 |
| 7.6.3 Image Reconstruction | 72 |
| 7.6.4 Interpretation | 74 |
| 7.6.5 Pitfalls | 78 |
| 8 Coronary Angiography After Surgical Revascularization | 80 |
---|
| 8.1 Imaging Pearls | 86 |
| 9 Perfusion and Delayed Enhancement Imaging | 88 |
---|
| 9.1 Overview | 88 |
| 9.2 MDCT for Detection of Myocardial Fibrosis and Viability | 89 |
| 9.3 Ischemia Detection by MDCT | 91 |
| 9.4 Imaging Pearls: Delayed Enhancement | 93 |
| 9.5 Imaging Pearls: Ischemia | 94 |
| 10 Cardiac SPECT and PET: Complementary Roles with Cardiac CT | 96 |
---|
| 10.1 Introduction | 96 |
| 10.2 Imaging for Prevention | 96 |
| 10.3 Imaging for Diagnosis | 98 |
| 10.4 Imaging for Intervention | 100 |
| 10.5 Imaging Pearls | 105 |
| 10.5.1 Imaging for Prevention | 105 |
| 10.5.2 Imaging for Diagnosis | 105 |
| 10.5.3 Imaging for Intervention | 105 |
| 11 CCT Imaging: Cardiac Electrophysiology Applications | 107 |
---|
| 11.1 Cardiovascular Substrates Associated with Sudden Cardiac Death | 107 |
| 11.2 Electrophysiologic Mapping and Radiofrequency Catheter Ablation | 108 |
| 11.2.1 Atrial Fibrillation Ablation | 108 |
| 11.3 Cardiac Resynchronization Therapy | 114 |
| 11.4 Imaging Pearls | 116 |
| 11.4.1 General | 116 |
| 11.4.2 Sudden Death Substrates | 116 |
| 11.4.3 Atrial Fibrillation Ablation | 116 |
| 11.4.4 Resynchronization Therapy | 117 |
| 12 Pericardial/Myocardial Disease Processes | 120 |
---|
| 12.1 Introduction | 120 |
| 12.2 CT Imaging of Myocardial Disease | 120 |
| 12.3 CT Imaging of Pericardial Disease | 123 |
| 12.4 Imaging Pearls | 126 |
| 13 Assessment of Cardiac and Thoracic Masses | 128 |
---|
| 13.1 Subject Overview | 128 |
| 13.2 Interpreting Cardiac Masses | 131 |
| 13.3 Clinical Pearls | 133 |
| 14 Computed Tomography Evaluation in Valvular Heart Disease | 140 |
---|
| 14.1 Introduction
|